Masimo receives FDA De Novo authorisation for ORi continuous parameter
ORi is intended to be used in conjunction with oxygen saturation (SpO2) to provide increased resolution of changes…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Oct 23
ORi is intended to be used in conjunction with oxygen saturation (SpO2) to provide increased resolution of changes…
13 Oct 23
CommandEP™ integrates existing 3D cardiac mapping systems to create a real time 3D holographic interface that provides physicians…
12 Oct 23
The first-in-human study intended to evaluate the feasibility of the method, the operation of the patented device, and…
12 Oct 23
Healthmark Industries is engaged in the development and marketing of solutions that supports healthcare facilities in providing surgical…
12 Oct 23
MediWound to join forces with 3M Health Care, world’s largest wound care company in pivotal study for patients…
12 Oct 23
S+N Academy Munich, situated in Kustermann Park in the heart of the city, will provide a central European…
11 Oct 23
SynchroMed III, an upgraded version of the SynchroMed II system, is a targeted drug delivery (TDD) platform intended…
11 Oct 23
The interoperability of Philips Capsule Medical Device Information Platform (MDIP) with Philips Patient Information Center iX (PIC iX)…
11 Oct 23
Velocity accelerates entrepreneurs’ growth from ideas to early-stage startups and beyond
11 Oct 23
Hammerdesis allows surgeons to correct hammertoe deformities and degenerative issues in patients by simply affixing a distinctively designed…